This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
industry-outlook: Archive
Chart Industries (GTLS) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Chart Industries (GTLS) delivered earnings and revenue surprises of -27.82% and -12.20%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
GTLSNegative Net Change BWENNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Arbor Realty Trust (ABR) Q4 Earnings Miss Estimates
by Zacks Equity Research
Arbor Realty Trust (ABR) delivered earnings and revenue surprises of -10.92% and +6.45%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ABRPositive Net Change FRGEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Globalstar (GSAT) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Globalstar (GSAT) delivered earnings and revenue surprises of -1,500.00% and +0.23%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
GSATPositive Net Change SATSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BlackRock TCP (TCPC) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
BlackRock TCP (TCPC) delivered earnings and revenue surprises of -10.35% and -8.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
TCPCNegative Net Change AFCGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LiqTech International, Inc. (LIQT) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
LiqTech International (LIQT) delivered earnings and revenue surprises of -58.82% and -39.90%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
LIQTPositive Net Change ALGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sunstone Hotel Investors (SHO) Surpasses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Sunstone Hotel (SHO) delivered FFO and revenue surprises of +9.35% and +4.29%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
SHONegative Net Change OLPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gogo (GOGO) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Gogo (GOGO) delivered earnings and revenue surprises of -166.67% and +3.36%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
GOGONegative Net Change ONDSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
by Zacks Equity Research
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +433.33% and -2.39%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
FLGTNegative Net Change LUNGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
1stdibs.com (DIBS) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
1stdibs (DIBS) delivered earnings and revenue surprises of +25.00% and -0.59%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
DIBSNegative Net Change PDDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ANI Pharmaceuticals (ANIP) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
ANI (ANIP) delivered earnings and revenue surprises of +17.32% and +6.04%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ANIPNegative Net Change CRMDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank